Impact of anesthetic agents on patients with sickle cell disease.
Fifty-two surgical procedures were performed on 45 patients with sickle cell anemia. All patients were managed perioperatively with hydration and were kept warm and well oxygenated. Patients were anesthetized with either halothane (n = 16), enflurane (n = 22), isoflurane (n = 6), or intravenous narcotics (n = 4). Four patients had epidural anesthesia. Perioperative morbidity was assessed using the criteria of atelectasis, urinary tract infection, wound infection, thrombophlebitis, drug reaction, hypotension, and vaso-occlusive crisis. The overall perioperative complication rate in this study was 45 per cent. Patients anesthetized with isoflurane and enflurane had postoperative morbidity rates of 83 and 59 per cent, respectively, while the patients anesthetized with halothane had a complication rate of 25 per cent. In all three groups, atelectasis was the main cause. No complications occurred in the epidural group. In the intravenous anesthesia group, one patient developed sickle cell crisis. It appears that the types of anesthetic agents used do not impact on postoperative morbidity in patients with sickle cell anemia more than any other type of patient.
Gross
M L
ML
Tulane University School of Medicine, New Orleans, Louisiana.
Schwedler
M
M
Bischoff
R J
RJ
Kerstein
M D
MD
D000328:Adult; D000755:Anemia, Sickle Cell; D000767:Anesthesia, Epidural; D000777:Anesthetics; D004737:Enflurane; D005260:Female; D006221:Halothane; D006801:Humans; D007530:Isoflurane; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D001261:Pulmonary Atelectasis / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D013514:Surgical Procedures, Operative
D000777:Anesthetics; D004737:Enflurane; D007530:Isoflurane; D006221:Halothane